Sorted by: Date Source

China Bio Week-in-Review: Trials and Deals

In SeekingAlpha ETFs - Posted 10 hours ago

The news in China biotech last week revolved around two major topics: trial results/approvals and deals. On the test results front, Bridge Laboratorie...

Tags: beijing biotech china data pharma phase

Genesis Pharma Completes 40-to-1 Reverse Split

In SeekingAlpha ETFs - Posted 2 days ago

Genesis Pharmaceuticals Enterprises (GNPH.OB) has effected a 40-to-1 reverse stock split and changed its ticker symbol to GNPH from the previous symbo...

Tags: pharma

Four Unique Ways to Play the Baby Boomer Market

In SeekingAlpha ETFs - Posted 3 days ago

The reality is that each second, we all get older. All the money in the world will not turn back the inevitable biological clock. This fact doesn't st...

Tags: health pharma

Simcere Shows Positive Data from Cancer Drug Trial

In SeekingAlpha ETFs - Posted 3 days ago

Simcere Pharma (SCR) reported that interim results from a Phase IV trial of its patented anti-cancer drug Endu showed the drug displayed both safety a...

Tags: china data pharma phase platinum

Direct To Consumer Ads: Wasted Money?

In In the Pipeline - Posted 4 days ago

It s a truism that half of all advertising dollars are wasted, but that no one buying the ads can be sure which half it is. Advertising from the dru...

Tags: disease pharma

Big Pharma Pipeline: Why So Dry?

In SeekingAlpha ETFs - Posted 5 days ago

Pharmaceutical companies are trading well below their historical P/E levels. To anyone who follows the industry, this comes as no surprise. After a sl...

Tags: pharma pipeline trading

Pharma Merger: Japans Shionogi Buys Atlanta's Sciele for $1.42 Billion

In SeekingAlpha ETFs - Posted 5 days ago

Shionogi & Co. (SGIOF.PK), a major Japanese drug manufacturer and US-based specialty pharmaceutical company Sciele Pharma, Inc. (SCRX), announced on M...

Tags: pharma

GSK s scary HIV ads are ok with me

In Health Business Blog - Posted 1 week ago

The Wall Street Journal (Glaxo s HIV-Drug Ads Draw Critics) and Wall Street Journal Health Blog (Are Ads for HIV Drugs Too Scary?) wrote earlier thi...

Tags: health pharma

SL Pharma Wins SFDA Approval for New Drug and a Clinical Trial

In SeekingAlpha ETFs - Posted 1 week ago

Beijing SL Pharmaceutical Co. Ltd. (SZSE: 002038) received SFDA approval to begin producing a hepatitis drug and a second SFDA authorization to begin ...

Tags: beijing china clinical trial pharma szse

SL Pharma Wins SFDA Approval for New Drug and a Clinical Trial

In SeekingAlpha Biotech Stocks - Posted 1 week ago

Beijing SL Pharmaceutical Co. Ltd. (SZSE: 002038) received SFDA approval to begin producing a hepatitis drug and a second SFDA authorization to begin ...

Tags: clinical trial pharma

Featured Investment Blogs

24/7 Wall St.
Insightful Analysis and Commentary for U.S. and Global Equity Investors...

Dealscape
...

Environmental Economics
Economists on Environmental and Natural Resources: News, Opinion, and Analysis...

Paul Kedrosky's Infectious Greed
Musing about technology, finance, venture capital, & the money culture with Paul Kedrosky...

Jeff Matthews Is Not Making This Up
The World of Wall Street in all its glory, and anything else that strikes our fancy. Informed observations about comp...

Stock Market Beat
Our beat is the stock market. Our job is to beat it....

TechCrunch
TechCrunch profiles the companies, products and events that are defining and transforming the new web. TechCrunch is ...

Trader Mike
Stock market commentary & trading ideas. Stock market weblog (blog), swing trading, day trading, stock picks, techni...

More Blogs